Last reviewed · How we verify
NCT06637917
Pulse Oximetry Performance Comparison in Newborns
trial testing OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System in Newborn in 120 participants. Completed in 18 September 2025.
18 September 2025
Quick facts
| Lead sponsor | Medtronic - MITG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 10 September 2024 |
| Primary completion | 18 September 2025 |
| Estimated completion | 18 September 2025 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System
- LNCS® NEO SpO2 Sensor with RAD-97™ Pulse CO-Oximeter
- 1041PTS (or similar) Kendall™ Neonatal Electrodes with IntelliVue MP5 Portable Patient Monitor
Conditions studied
- Newborn — all drugs for Newborn →
- Birth, Preterm — all drugs for Birth, Preterm →
Sponsor
Medtronic - MITG — full company profile →
Who can join
29 Weeks and older, any sex, with Newborn or Birth, Preterm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall purpose is to directly compare pulse rate (PR) acquisition and oxygen saturation performance between two pulse oximeters (PO) in newborns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06637917
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Newborn
Currently open trials in the same condition.
- NCT07081048 — Pain and Comfort Levels During Heel Stick Blood Sampling in Newborns · NA · recruiting
- NCT06435572 — Comparison of Open and Closed Aspiration in Newborns · NA · recruiting
- NCT06368154 — Exosome microRNAs as Potential Biomarkers of Metabolic Bone Disease of Prematurity · recruiting
- NCT03931707 — The China Neonatal Genomes Project · recruiting
Other Medtronic - MITG trials
Trials by the same sponsor.
- NCT07351071 — Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res · NA · recruiting
- NCT07166341 — Accuracy Verification of the INVOS PM7100 · active not recruiting
- NCT07201961 — Nellcor™ Abbreviated Sensor Additional Data Collection · completed
- NCT06710795 — AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair · NA · active not recruiting
- NCT06638073 — Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department o · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06637917 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medtronic - MITG
- Last refreshed: 12 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06637917.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing